Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial

MLA

Elodie Coquan, et al. “Carboplatin in Metastatic Castration-Resistant Prostate Cancer Patients with Molecular Alterations of the DNA Damage Repair Pathway: The PRO-CARBO Phase II Trial.” Therapeutic Advances in Urology, vol. 16, Feb. 2024. EBSCOhost, https://doi.org/10.1177/17562872241229876.

APA

Elodie Coquan, Nicolas Penel, Justine Lequesne, Raphaël Leman, Pernelle Lavaud, Zoé Neviere, Pierre-Emmanuel Brachet, Emeline Meriaux, Aurélien Carnot, Jérémy Boutrois, Marie Castera, Nicolas Goardon, Etienne Muller, Alexandra Leconte, Antoine Thiery-Vuillemin, Bénédicte Clarisse, & Florence Joly. (2024). Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial. Therapeutic Advances in Urology, 16. https://doi.org/10.1177/17562872241229876

Chicago

Elodie Coquan, Nicolas Penel, Justine Lequesne, Raphaël Leman, Pernelle Lavaud, Zoé Neviere, Pierre-Emmanuel Brachet, et al. 2024. “Carboplatin in Metastatic Castration-Resistant Prostate Cancer Patients with Molecular Alterations of the DNA Damage Repair Pathway: The PRO-CARBO Phase II Trial.” Therapeutic Advances in Urology 16 (February). doi:10.1177/17562872241229876.